PubMed:16177264 / 118-298 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T3","span":{"begin":0,"end":8},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"T4","span":{"begin":69,"end":77},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"T5","span":{"begin":153,"end":161},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":37,"end":42},"obj":"HP_0002664"},{"id":"T2","span":{"begin":69,"end":84},"obj":"HP_0012125"},{"id":"T3","span":{"begin":78,"end":84},"obj":"HP_0002664"},{"id":"T4","span":{"begin":146,"end":173},"obj":"HP_0008711"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"ICD10","denotations":[{"id":"T1","span":{"begin":153,"end":173},"obj":"http://purl.bioontology.org/ontology/ICD10/N40"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"uniprot-human","denotations":[{"id":"T3","span":{"begin":27,"end":30},"obj":"http://www.uniprot.org/uniprot/P07288"},{"id":"T15","span":{"begin":0,"end":25},"obj":"http://www.uniprot.org/uniprot/Q16305"},{"id":"T17","span":{"begin":27,"end":30},"obj":"http://www.uniprot.org/uniprot/Q9Y617"},{"id":"T29","span":{"begin":27,"end":30},"obj":"http://www.uniprot.org/uniprot/P55786"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"uniprot-mouse","denotations":[{"id":"T2","span":{"begin":27,"end":30},"obj":"http://www.uniprot.org/uniprot/Q11011"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T3","span":{"begin":78,"end":84},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T3","span":{"begin":0,"end":8},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"T4","span":{"begin":69,"end":77},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"T5","span":{"begin":153,"end":161},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Lectin","denotations":[{"id":"Lectin_T2","span":{"begin":27,"end":30},"obj":"https://acgg.asia/db/lfdb/LfDB0181"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"mondo_disease","denotations":[{"id":"T2","span":{"begin":37,"end":42},"obj":"Disease"},{"id":"T3","span":{"begin":69,"end":84},"obj":"Disease"},{"id":"T4","span":{"begin":86,"end":89},"obj":"Disease"},{"id":"T5","span":{"begin":138,"end":141},"obj":"Disease"},{"id":"T6","span":{"begin":146,"end":173},"obj":"Disease"},{"id":"T7","span":{"begin":175,"end":178},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0010811"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0010811"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Anatomy-MAT","denotations":[{"id":"T3","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T4","span":{"begin":69,"end":77},"obj":"Body_part"},{"id":"T5","span":{"begin":153,"end":161},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"HP-phenotype","denotations":[{"id":"T2","span":{"begin":37,"end":42},"obj":"Phenotype"},{"id":"T3","span":{"begin":69,"end":84},"obj":"Phenotype"},{"id":"T4","span":{"begin":86,"end":89},"obj":"Phenotype"},{"id":"T5","span":{"begin":138,"end":141},"obj":"Phenotype"},{"id":"T6","span":{"begin":146,"end":173},"obj":"Phenotype"},{"id":"T7","span":{"begin":175,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0012125"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0012125"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0012125"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0008711"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"HP:0008711"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T2","span":{"begin":37,"end":42},"obj":"Phenotype"},{"id":"T3","span":{"begin":69,"end":84},"obj":"Phenotype"},{"id":"T4","span":{"begin":86,"end":89},"obj":"Phenotype"},{"id":"T5","span":{"begin":138,"end":141},"obj":"Phenotype"},{"id":"T6","span":{"begin":146,"end":173},"obj":"Phenotype"},{"id":"T7","span":{"begin":175,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0012125"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0012125"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0012125"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0008711"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"HP:0008711"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T2","span":{"begin":37,"end":42},"obj":"Disease"},{"id":"T3","span":{"begin":69,"end":84},"obj":"Disease"},{"id":"T4","span":{"begin":86,"end":89},"obj":"Disease"},{"id":"T5","span":{"begin":138,"end":141},"obj":"Disease"},{"id":"T6","span":{"begin":146,"end":173},"obj":"Disease"},{"id":"T7","span":{"begin":175,"end":178},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0010811"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0010811"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T4","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T5","span":{"begin":69,"end":77},"obj":"Body_part"},{"id":"T6","span":{"begin":153,"end":161},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T3","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T4","span":{"begin":69,"end":77},"obj":"Body_part"},{"id":"T5","span":{"begin":153,"end":161},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000078"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"GlyCosmos15-Lectin-Jamboree","denotations":[{"id":"T2","span":{"begin":27,"end":30},"obj":"Lectin"}],"attributes":[{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"GL_000021"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Lectin-Jamboree-small","denotations":[{"id":"T2","span":{"begin":27,"end":30},"obj":"Lectin"}],"attributes":[{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"GL_000021"}],"namespaces":[{"prefix":"_base","uri":"https://glycosmos.org/lectins/"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T2","span":{"begin":0,"end":180},"obj":"Sentence"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T5","span":{"begin":69,"end":77},"obj":"Body_part"},{"id":"T6","span":{"begin":153,"end":161},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"}],"text":"Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH)."}